Gilinski’s $1 Billion Bid Raises Stakes in Colombia Battle
(Bloomberg) -- Jaime Gilinski is making a fresh run at taking control of Colombia's largest business group with a $1 billion bid to increase his ownership stakes of a financial conglomerate and the country's largest food maker.
Gilinski, a banking billionaire and one of Colombia's richest men, is offering to buy as much as $690 million worth of Grupo Nutresa SA, a maker of snacks, chocolates, coffees and cold cuts, for $12.58 a share. A simultaneous offer to investors in Grupo de Inversiones Suramericana SA for $9.88 per share would give Gilinski as much as roughly $300 million more of the banking and insurance holding.
The offers, announced by regulators late Monday, came just hours after a previous round of bids expired. Gilinski and Abu Dhabi's royal family have already invested $2.4 billion in the companies since November, making him the largest shareholder in Grupo Sura and the second largest in Nutresa. Both bids may run until April, according to a person familiar with the matter.
Still, he's been rebuffed in his ultimate goal of taking control of an alliance of Medellin-based businesses, known as the Grupo Empreserial Antioqueno, or GEA. Nutresa, Sura and infrastructure conglomerate Grupo Argos SA are members of the GEA, which employs a system of cross ownership to protect themselves from takeover attempts.
Read More: Colombian Billionaire Gilinski Boosts Stakes in Nutresa and Sura
Gilinski's latest offers appear to be aimed at convincing Argos to sell at least some of the 9.88% it owns of Nutresa and the 27.76% of Sura. Argos's board of directors has rejected the last two offers, relying on analyses by JPMorgan Chase & Co. that found the first offer “significantly underestimated” the value of Nutresa and the second was “inferior to the fundamental value” of Sura and Nutresa, according to regulatory filings.
Sweetened Deal
Gilinski's latest offer represents a 127% premium for Nutresa compared to the closing price before the first offer was announced in November, according to BTG Pactual. The offer for Sura is at an 83% premium. Still, they don't expect the GEA to participate “despite Gilinski sweetening the deal,” analysts Daniel Guardiola and Daniel Callamand wrote in a note Tuesday.
“At the price of the new offers, Grupo Argos' stake in Grupo Sura and Nutresa is worth $2 billion,” the analysts wrote. “In our base-case, we don't expect GEA holding companies to tender.”
Even at current levels, Gilinski is likely to gain at least two board seats in both Nutresa and Sura, putting him in position to wield influence over business decisions. He's so far fallen short, however, of gaining a majority stake in any of the companies.
Gilinski is seeking to gain an additional 12% stake in Nutresa in a joint venture with the Royal Group, an investment vehicle linked to Abu Dhabi's royal family. He's also seeking as much as 6.5% more of Sura in a deal in which the Royal Group is not involved. If he's successful, he'd obtain a total of around 42% of Nutresa, potentially enough to win a third board seat.
Shares in the companies have been suspended as regulators evaluate the bids.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.